NCT05550324 IPSC Repository of Pediatric Cardiovascular Disease
| NCT ID | NCT05550324 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mingtao Zhao |
| Condition | Congenital Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2021-07-02 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2021-07-02 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obtain blood samples for generation and maintenance of induced pluripotent stem cells (iPSCs) and genomic/DNA sequencing for biomedical research that will improve the understanding and treatment of pediatric cardiovascular disease
Eligibility Criteria
Inclusion Criteria: 1. The subjects must have the diagnosis of cardiovascular disease 2. The subject must have a syndrome associated with cardiovascular disease 3. The subject must be related to an individual in cohort 1 or 2 4. The subject is considered a control and does not fall into any of the other cohorts Exclusion Criteria: N/A
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05550324 clinical trial?
This trial is open to participants of all sexes, studying Congenital Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05550324 currently recruiting?
Yes, NCT05550324 is actively recruiting participants. Contact the research team at jade.hayden@nationwidechildrens.org for enrollment information.
Where is the NCT05550324 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT05550324 clinical trial?
NCT05550324 is sponsored by Mingtao Zhao. The trial plans to enroll 300 participants.